Author Archive

On A Big Anniversary, Four Ways Obamacare Has — And Hasn’t — Changed

Two years ago tomorrow, the Supreme Court changed the law that changed an industry. The Court’s June 28, 2012, decision to uphold the Affordable Care Act—by the slender margin of a single vote—did more than allow the

Five UK Headlines That Foretell Obamacare’s Future — And Yours

I just spent a week in Wales for the BBC.  Near my hotel in Cardiff on Queen Street is a large statue of Aneurin Bevan, the Welsh-born Labor Party member of Parliament and founder of Great Britain’s

Seniors Flock To Star-Rated Medicare Plans Under ACA Rollout

An effort under the Affordable Care Act to encourage the health insurance industry to provide higher quality benefits to seniors is rewarding Medicare beneficiaries and the bottom lines of  health plans that are achieving high government-backed ratings.

Perspectives On Obamacare’s First Year Enrollment

The day that many health policy wonks have been waiting for has come: Obamacare’s first open–enrollment period has officially ended on April 15, 2014. Wasting little time, the Department of Health and Human Services (HHS) has released the last of its

What Role Should Coca-Cola Play In Obesity Research?

What role should Coca-Cola Coca-Cola and other food and beverage companies play in funding and communicating research about nutrition and obesity? The question is prompted by a recent article in the Journal of the American College of Cardiology. The “state-of-the-art” paper

Wow. Agios’ Experimental Leukemia Drug Makes Cancer Undetectable In Three Patients

Agios, a biotechnology company based in Cambridge, Mass., has seemed in some ways a sign of the overexcitement of the recent biotech boom. After all, the company, despite an experienced management team, a July public stock offering

Whither Japan Stocks: Looking For Opportunities In The ‘Post-Abenomics’ Market

Sell side analysts always find something bullish to say about the market. For investors the watchword is caveat emptor.  As an investor, what to think about Japanese stocks now? It should go without saying that Japan’s mainstream

Worried About Measles? Don’t Call Dr. Bob Sears

Dr. Bob Sears once wrote a non-evidence-based book about vaccines, urging parents to adopt “Dr. Bob’s Alternative Vaccine Schedule (TM?)” but at the least, to please purchase his book. Thousands of people, presumably terrified at the prospect

Hundreds Drop Resumes at Colorado’s First Cannabis Career Fair

This week marked a first for Colorado and the cannabis industry as a whole: its first ever job fair. The event was held in the downtown Denver headquarters of cannabis vaporizing device manufacturer O.penVAPE which organized the

Clock Is Ticking For AstraZeneca

This morning Eli Lilly Co Eli Lilly Co. (LLY) released top-line results for the sixth AWARD study for their once-weekly GLP-1 dulaglutide. According to a company issued press release; “In the AWARD-6 study, once-weekly dulaglutide 1.5 mg